Literature DB >> 10540177

Properdin deficiency and meningococcal disease--identifying those most at risk.

S M Linton1, B P Morgan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10540177      PMCID： PMC1905414          DOI： 10.1046/j.1365-2249.1999.01057.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  25 in total

Review 1.  Complement deficiency and disease.

Authors:  B P Morgan; M J Walport
Journal:  Immunol Today       Date:  1991-09

2.  Genetic and physical mapping around the properdin P gene.

Authors:  M P Coleman; J C Murray; H F Willard; K F Nolan; K B Reid; D J Blake; S Lindsay; S S Bhattacharya; A Wright; K E Davies
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

3.  Congenital properdin deficiency and meningococcal infection.

Authors:  H E Nielsen; C Koch
Journal:  Clin Immunol Immunopathol       Date:  1987-08

4.  Dysfunctional properdin in a Dutch family with meningococcal disease.

Authors:  A G Sjöholm; E J Kuijper; C C Tijssen; A Jansz; P Bol; L Spanjaard; H C Zanen
Journal:  N Engl J Med       Date:  1988-07-07       Impact factor: 91.245

5.  Analysis of the natural polymeric forms of human properdin and their functions in complement activation.

Authors:  M K Pangburn
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

6.  Polymorphism of IgG Fc receptors in meningococcal disease.

Authors:  C A Fijen; R G Bredius; E J Kuijper
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

7.  Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs.

Authors:  D Goundis; K B Reid
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

8.  Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement.

Authors:  K F Nolan; W Schwaeble; S Kaluz; M P Dierich; K B Reid
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

Review 9.  Inherited complement deficiency states: implications for immunity and immunological disease.

Authors:  A G Sjöholm
Journal:  APMIS       Date:  1990-10       Impact factor: 3.205

Review 10.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132
View more
  12 in total

Review 1.  Modern complement analysis.

Authors:  Michael Kirschfink; Tom E Mollnes
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Complement factor P: promoting the antibacterial activity of natural killer cells.

Authors:  Xiaoxuan Zhuang; Eric O Long
Journal:  Cell Mol Immunol       Date:  2017-07-24       Impact factor: 11.530

3.  Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab?

Authors:  Kate Smith-Jackson; Kevin J Marchbank
Journal:  Ann Transl Med       Date:  2018-11

4.  Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation.

Authors:  Yuan Wang; Takashi Miwa; Blerina Ducka-Kokalari; Imre G Redai; Sayaka Sato; Damodar Gullipalli; James G Zangrilli; Angela Haczku; Wen-Chao Song
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

5.  A novel mutation W388X underlying properdin deficiency in a Finnish family.

Authors:  M Helminen; S Seitsonen; H Jarva; S Meri; I E Järvelä
Journal:  Scand J Immunol       Date:  2012-04       Impact factor: 3.487

6.  Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.

Authors:  Yuko Kimura; Takashi Miwa; Lin Zhou; Wen-Chao Song
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

7.  Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection.

Authors:  Youssif Mohammed Ali; Azam Hayat; Bayad Mawlood Saeed; Kashif S Haleem; Saleh Alshamrani; Hany I Kenawy; Viviana P Ferreira; Gurpanna Saggu; Anna Buchberger; Peter J Lachmann; Robert B Sim; Dimitrios Goundis; Peter W Andrew; Nicholas J Lynch; Wilhelm J Schwaeble
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

8.  A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.

Authors:  Diana Pauly; Benedikt M Nagel; Jörg Reinders; Tobias Killian; Matthias Wulf; Susanne Ackermann; Boris Ehrenstein; Peter F Zipfel; Christine Skerka; Bernhard H F Weber
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

9.  Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.

Authors:  Marloes A H M Michels; Nicole C A J van de Kar; Ramon M van den Bos; Thea J A M van der Velden; Sanne A W van Kraaij; Sebastian A Sarlea; Valentina Gracchi; Michiel J S Oosterveld; Elena B Volokhina; Lambertus P W J van den Heuvel
Journal:  Front Immunol       Date:  2019-06-17       Impact factor: 7.561

10.  Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.

Authors:  Rosa G M Lammerts; Ditmer T Talsma; Wendy A Dam; Mohamed R Daha; Marc A J Seelen; Stefan P Berger; Jacob van den Born
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.